Filing Details
- Accession Number:
- 0001655759-25-000105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-18 18:04:06
- Reporting Period:
- 2025-06-17
- Filing Date:
- 2025-06-18
- Accepted Time:
- 2025-06-18 18:04:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1655759 | Arvinas Inc. | ARVN | Pharmaceutical Preparations (2834) | 472566120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2026306 | M Angela Cacace | C/O Arvinas, Inc. 5 Science Park, 395 Winchester Ave. New Haven CT 06511 | Chief Scientific Officer | No | Yes | No | No |
Transaction Summary
| Sold: | 2,583 shares | Avg. Price: $7.49 | Total Value: $19,346.67 |
| Number of Shares After Transactions: | 154,248 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-17 | 2,583 | $7.49 | 154,248 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 50% of the reporting person's restricted stock units (RSUs) granted on June 17, 2024.
Billionaire Hedge Funds
